Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Phenotype C1134719|invasive ductal carcinoma
Sentences 21
PubMedID- 24559611 Accompanying dcis in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
PubMedID- 23046680 Thirty breast cancer patients diagnosed with invasive ductal carcinoma from unimed medical institute, hong kong gave consent to participate in this study.
PubMedID- 23711151 From january 2002 to december 2004, all the sporadic breast cancer patients with invasive ductal carcinoma who were selected to undergo surgery and adjuvant chemotherapy (cyclophosphamide 100 mg/m2 d1, doxorubicin 30 mg/m2 d1,8, and fluorouracil 500 mg/m2 d1,8; all drugs given intravenously (iv) every 28 days, for a total of six cycles) were eligible for the present study.
PubMedID- 25710561 Detected this snp in chinese breast cancer patients with invasive ductal carcinomas [97].
PubMedID- 22908313 Menainv, a mena isoform expressed in asubpopulation of highly invasive, motile, and chemotactic tumor cells (goswami et al., 2009), has been detected inbreast cancer patients with invasive ductal carcinomas (roussos et al., 2011b).
PubMedID- 25961581 In this study, we investigated the expression of ano1 in 431 breast cancer patients with invasive ductal carcinoma (idc).
PubMedID- 21658254 Frozen sample-pair specimens from 15 breast cancer patients diagnosed with invasive ductal carcinoma were obtained from the uams tissue bank.
PubMedID- 25750340 Case-case study: 400 breast cancer patients, with invasive ductal carcinoma (idc) treated with anthracycline based-chemotherapy.
PubMedID- 22523546 Methodology/principal findings: circulating mirnas in blood serum prior to treatment were determined by quantitative real-time pcr in 56 breast cancer patients with invasive ductal carcinoma and pre-operative neoadjuvant chemotherapy.
PubMedID- 21969203 Both breast cancers were consistent with stage i invasive ductal carcinomas.
PubMedID- 22782361 Methods: we examined 408 japanese breast cancers with invasive ductal carcinoma and studied the correlation between ki-67 labeling index and er/her2 status and histological grade of breast cancer.
PubMedID- 24724090 For breast cancer patients with an invasive ductal carcinoma of 1.5–3 cm in size, the total choline level in tumors measured by 1h-mrs was highly correlated with the standardized 18f-fdg uptake value obtained by pet/ct, and these measurements were also supported by the histologic prognostic parameters (nuclear grade, estrogen receptor status, and triple-negative lesion status) [128].
PubMedID- 23555296 However, one study found that although significant microhomology was found at chromosome fusions in fibroblasts in crisis and in the invasive ductal carcinoma stage of breast cancer, no significant microhomology was found in the ductal carcinoma in situ stage of breast cancer, suggesting that chromosome fusions commonly occur by c-nhej in early stages of breast cancer [91].
PubMedID- 26089588 Supplementary table 2 contained the information regarding the histopathological parameters of study cohort and majority of breast cancer patients were with invasive ductal carcinoma with grade-ii and negative er, pr and her-2/neu status.
PubMedID- 21151530 Furthermore, hermark positive breast cancers were significantly associated with invasive ductal carcinoma, high tumor grade, estrogen/progesterone receptor negativity, and expression of ki67 [38].
PubMedID- 26106384 In tumors, the density of stromal lyve-1 positive lymphatic vessels is a negative prognostic indicator in breast cancer patients with invasive ductal carcinomas (54).
PubMedID- 25534095 Methods: twenty cases of surgical removal of breast cancer tissue (diagnosed with invasive ductal carcinoma, stage ii, by postoperative paraffin pathology) and normal breast tissues adjacent to carcinoma were collected during june 2013 to august 2013.quantitative real-time pcr (qrt-pcr) was performed to detect the yb1 mrna levels.
PubMedID- 20304650 Purpose: we designed this study to identify differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma (impc) and invasive ductal carcinoma (idc) in patients with breast cancer.
PubMedID- PMC3849464 An application on histological types of breast cancer is presented with vsi of invasive ductal carcinoma and mastosis.
PubMedID- 25409150 We are presenting the case of a 60-year-old breast cancer patient diagnosed with invasive ductal carcinoma that underwent surgery followed by adjuvant treatment with chemotherapy and the aromatase inhibitor examestane.
PubMedID- 26400100 Paraffin-embedded specimens from 118 breast cancer patients with invasive ductal carcinoma (idc), diagnosed between 2003 and 2004, together with 44 cases of breast ductal carcinoma in situ (dcis) and 34 cases of benign breast lesions were reviewed and selected from the archives of the department of breast cancer pathology and research laboratory, tianjin medical university cancer institute & hospital (tianjin, china).

Page: 1